ALPA LABORATORIES
|
ALPA LABORATORIES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 5.98 | 6.70 | 3.44 | 0.88 | 0.48 |
| CEPS(Rs) | 6.61 | 7.48 | 4.03 | 2.38 | 1.96 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 63.96 | 57.86 | 51.16 | 47.70 | 46.81 |
| Tax Rate(%) | 20.81 | 27.96 | 32.81 | 36.25 | 63.29 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 8.69 | 9.50 | 7.89 | 3.90 | 1.47 |
| EBIT Margin(%) | 17.34 | 17.62 | 11.14 | 3.61 | 4.26 |
| Pre Tax Margin(%) | 17.09 | 17.42 | 11.06 | 3.38 | 3.53 |
| PAT Margin (%) | 13.54 | 12.55 | 7.43 | 2.16 | 1.30 |
| Cash Profit Margin (%) | 14.97 | 14.03 | 8.69 | 5.84 | 5.30 |
| Performance Ratios | |||||
| ROA(%) | 7.80 | 9.53 | 5.56 | 1.54 | 0.84 |
| ROE(%) | 9.82 | 12.29 | 6.97 | 1.86 | 1.03 |
| ROCE(%) | 12.19 | 16.81 | 10.42 | 3.09 | 3.26 |
| Asset Turnover(x) | 0.58 | 0.76 | 0.75 | 0.71 | 0.65 |
| Sales/Fixed Asset(x) | 2.74 | 3.45 | 2.76 | 2.18 | 2.03 |
| Working Capital/Sales(x) | 0.78 | 1.03 | 1.10 | 1.15 | 1.09 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.37 | 0.29 | 0.36 | 0.46 | 0.49 |
| Receivable days | 166.43 | 119.43 | 112.28 | 115.88 | 131.09 |
| Inventory Days | 55.18 | 52.06 | 54.46 | 56.45 | 64.97 |
| Payable days | 99.58 | 103.71 | 117.94 | 96.23 | 98.90 |
| Valuation Parameters | |||||
| PER(x) | 8.99 | 10.38 | 10.50 | 16.01 | 55.11 |
| PCE(x) | 8.13 | 9.29 | 8.97 | 5.91 | 13.50 |
| Price/Book(x) | 0.84 | 1.20 | 0.71 | 0.30 | 0.57 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.15 | 1.34 | 0.67 | 0.28 | 0.72 |
| EV/Core EBITDA(x) | 6.11 | 7.02 | 5.44 | 3.81 | 8.77 |
| EV/EBIT(x) | 6.62 | 7.61 | 6.05 | 7.70 | 17.00 |
| EV/CE(x) | 0.64 | 0.97 | 0.47 | 0.20 | 0.47 |
| M Cap / Sales | 1.22 | 1.30 | 0.78 | 0.35 | 0.71 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -17.20 | 15.08 | 13.48 | 10.23 | 24.09 |
| Core EBITDA Growth(%) | -18.63 | 77.27 | 92.93 | -2.72 | -26.65 |
| EBIT Growth(%) | -18.54 | 82.07 | 250.05 | -6.66 | -41.79 |
| PAT Growth(%) | -10.71 | 94.45 | 291.02 | 83.20 | -63.96 |
| EPS Growth(%) | -10.71 | 94.45 | 291.02 | 83.20 | -63.96 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.02 | 0.05 | - | - | 0.02 |
| Current Ratio(x) | 5.03 | 4.79 | 3.73 | 4.59 | 4.22 |
| Quick Ratio(x) | 4.61 | 4.25 | 3.22 | 3.99 | 3.59 |
| Interest Cover(x) | 72.07 | 90.32 | 139.47 | 15.82 | 5.85 |
| Total Debt/Mcap(x) | 0.02 | 0.04 | - | 0.01 | 0.03 |
Compare Financial Ratios of peers of ALPA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALPA LABORATORIES | ₹203.6 Cr | 4.2% | 10.3% | 57.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹360,920.0 Cr | -2.3% | -6.5% | 55.3% | Stock Analytics | |
| CIPLA | ₹113,794.0 Cr | 4.1% | -4.8% | 55.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹106,860.0 Cr | 7.8% | 17.4% | 20.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,316.0 Cr | 4% | 0.8% | 29.4% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹95,380.9 Cr | -1.2% | -5.2% | 83.9% | Stock Analytics | |
ALPA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALPA LABORATORIES | 4.2% |
10.3% |
57.3% |
| SENSEX | 0.9% |
1.5% |
23.6% |
You may also like the below Video Courses
